Literature DB >> 17158237

p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres.

Pasquale Sansone1, Gianluca Storci, Catia Giovannini, Silvia Pandolfi, Simona Pianetti, Mario Taffurelli, Donatella Santini, Claudio Ceccarelli, Pasquale Chieco, Massimiliano Bonafé.   

Abstract

The comprehension of the basic biology of stem cells is expected to provide a useful insight into the pathogenesis of cancer. In particular, there is evidence that hypoxia promotes stem cell renewal in vitro as well as in vivo. It therefore seems reasonable that stem cell survival and hypoxia response are strictly connected at molecular level. We here report that the 66-kDa isoform of the SHC gene (p66Shc) is induced in a breast cancer cell line by the exposure to hypoxic environment and that it controls the expression of the stem cell regulatory gene Notch-3. Then, we show that p66Shc/Notch-3 interplay modulates self-renewal (by inducing the Notch-ligand Jagged-1) and hypoxia survival (by inducing the hypoxia-survival gene carbonic anhydrase IX) in mammary gland stem/progenitor cells, expanded in vitro as multicellular spheroids (mammospheres). We conclude that mechanisms that regulate stem cell renewal and hypoxia survival are integrated at the level of the p66Shc/Notch3 interplay. Because Notch-3, Jagged-1, and carbonic anhydrase IX are dysregulated in breast cancer, and because p66Shc is an aging-regulating gene, we envision that these data may help in understanding the relationship among aging, cancer, and stem cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158237     DOI: 10.1634/stemcells.2006-0442

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  86 in total

Review 1.  Targeting Notch to target cancer stem cells.

Authors:  Antonio Pannuti; Kimberly Foreman; Paola Rizzo; Clodia Osipo; Todd Golde; Barbara Osborne; Lucio Miele
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

Review 2.  Targeting breast cancer stem cells.

Authors:  Suling Liu; Max S Wicha
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

Review 3.  Hypoxia, notch signalling, and prostate cancer.

Authors:  Laure Marignol; Karla Rivera-Figueroa; Thomas Lynch; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

4.  The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis.

Authors:  Luke Martin McCaffrey; Ian G Macara
Journal:  Genes Dev       Date:  2009-06-15       Impact factor: 11.361

5.  Notch3-Jagged signaling controls the pool of undifferentiated airway progenitors.

Authors:  Munemasa Mori; John E Mahoney; Maria R Stupnikov; Jesus R Paez-Cortez; Aleksander D Szymaniak; Xaralabos Varelas; Dan B Herrick; James Schwob; Hong Zhang; Wellington V Cardoso
Journal:  Development       Date:  2015-01-15       Impact factor: 6.868

6.  Nuclear receptors agonists exert opposing effects on the inflammation dependent survival of breast cancer stem cells.

Authors:  A Papi; T Guarnieri; G Storci; D Santini; C Ceccarelli; M Taffurelli; S De Carolis; N Avenia; A Sanguinetti; A Sidoni; M Orlandi; M Bonafé
Journal:  Cell Death Differ       Date:  2012-01-20       Impact factor: 15.828

7.  Targeting Met and Notch in the Lfng-deficient, Met-amplified triple-negative breast cancer.

Authors:  Shubing Zhang; Wen-cheng Chung; Lucio Miele; Keli Xu
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

Review 8.  Notch inhibitors for cancer treatment.

Authors:  Ingrid Espinoza; Lucio Miele
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 9.  P66Shc signals to age.

Authors:  Mirella Trinei; Ina Berniakovich; Elena Beltrami; Enrica Migliaccio; Ambrogio Fassina; PierGiuseppe Pelicci; Marco Giorgio
Journal:  Aging (Albany NY)       Date:  2009-06-05       Impact factor: 5.682

10.  Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.

Authors:  G Liu; A Bollig-Fischer; B Kreike; M J van de Vijver; J Abrams; S P Ethier; Z-Q Yang
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.